{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:41:25Z","timestamp":1792575685336,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"DOI":"10.1007\/s10840-026-02296-9","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T09:05:40Z","timestamp":1774515940000},"page":"1789-1801","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trial emulation of percutaneous left atrial appendage occlusion versus direct oral anticoagulants"],"prefix":"10.1007","volume":"69","author":[{"given":"Mohammed","family":"Ruzieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanxing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Foy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Blotner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald V.","family":"Naccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mandrola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2608-616X","authenticated-orcid":false,"given":"Tianze","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,26]]},"reference":[{"issue":"10","key":"2296_CR1","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","volume":"139","author":"EJ Benjamin","year":"2019","unstructured":"Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics-2019 update: a report from the American Heart Association. Circulation. 2019;139(10):e56\u2013528.","journal-title":"Circulation"},{"issue":"18","key":"2296_CR2","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go AS, Hylek EM, Phillips KA, et al. Prevalence of diagnosed atrial fibrillation in adultsNational implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285(18):2370\u20135. https:\/\/doi.org\/10.1001\/jama.285.18.2370.","journal-title":"JAMA"},{"issue":"9","key":"2296_CR3","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/archinte.1987.00370090041008","volume":"147","author":"PA Wolf","year":"1987","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med. 1987;147(9):1561\u20134.","journal-title":"Arch Intern Med"},{"issue":"4","key":"2296_CR4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.amjcard.2009.10.018","volume":"105","author":"J Menke","year":"2010","unstructured":"Menke J, L\u00fcthje L, Kastrup A, Larsen J. Thromboembolism in atrial fibrillation. Am J Cardiol. 2010;105(4):502\u201310. https:\/\/doi.org\/10.1016\/j.amjcard.2009.10.018.","journal-title":"Am J Cardiol"},{"issue":"2","key":"2296_CR5","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1161\/01.STR.16.2.182","volume":"16","author":"M Britton","year":"1985","unstructured":"Britton M, Gustafsson C. Non-rheumatic atrial fibrillation as a risk factor for stroke. Stroke. 1985;16(2):182\u20138. https:\/\/doi.org\/10.1161\/01.STR.16.2.182.","journal-title":"Stroke"},{"issue":"7","key":"2296_CR6","doi-asserted-by":"publisher","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","volume":"131","author":"RG Hart","year":"1999","unstructured":"Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999;131(7):492\u2013501. https:\/\/doi.org\/10.7326\/0003-4819-131-7-199910050-00003.","journal-title":"Ann Intern Med"},{"issue":"4","key":"2296_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1161\/CIRCULATIONAHA.121.056355","volume":"145","author":"AP Carnicelli","year":"2022","unstructured":"Carnicelli AP, Hong H, Connolly SJ, et al. Direct oral anticoagulants versus warfarin in patients with atrial fibrillation: patient-level network meta-analyses of randomized clinical trials with interaction testing by age and sex. Circulation. 2022;145(4):242\u201355. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.056355.","journal-title":"Circulation"},{"issue":"6","key":"2296_CR8","doi-asserted-by":"publisher","first-page":"e366","DOI":"10.1016\/j.amjmed.2020.11.024","volume":"134","author":"GV Naccarelli","year":"2021","unstructured":"Naccarelli GV, Ruzieh M, Wolbrette DL, et al. Oral anticoagulation use in high-risk patients is improved by elimination of false-positive and inactive atrial fibrillation cases. Am J Med. 2021;134(6):e366\u201373. https:\/\/doi.org\/10.1016\/j.amjmed.2020.11.024.","journal-title":"Am J Med"},{"issue":"2","key":"2296_CR9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/0735-1097(94)00396-8","volume":"25","author":"MF Stoddard","year":"1995","unstructured":"Stoddard MF, Dawkins PR, Prince CR, Ammash NM. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol. 1995;25(2):452\u20139. https:\/\/doi.org\/10.1016\/0735-1097(94)00396-8.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2296_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.0954-6820.1969.tb07351.x","volume":"185","author":"H Aberg","year":"1969","unstructured":"Aberg H. Atrial fibrillation. I. A study of atrial thrombosis and systemic embolism in a necropsy material. Acta Med Scand. 1969;185(5):373\u20139.","journal-title":"Acta Med Scand"},{"issue":"19","key":"2296_CR11","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1001\/jama.2014.15192","volume":"312","author":"VY Reddy","year":"2014","unstructured":"Reddy VY, Sievert H, Halperin J, et al. Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation: A Randomized Clinical Trial. JAMA. 2014;312(19):1988\u201398. https:\/\/doi.org\/10.1001\/jama.2014.15192.","journal-title":"JAMA"},{"issue":"1","key":"2296_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","volume":"64","author":"DR Holmes","year":"2014","unstructured":"Holmes DR, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1\u201312. https:\/\/doi.org\/10.1016\/j.jacc.2014.04.029.","journal-title":"J Am Coll Cardiol"},{"issue":"13","key":"2296_CR13","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","volume":"75","author":"JV Freeman","year":"2020","unstructured":"Freeman JV, Varosy P, Price MJ, et al. The NCDR left atrial appendage occlusion registry. J Am Coll Cardiol. 2020;75(13):1503\u201318. https:\/\/doi.org\/10.1016\/j.jacc.2019.12.040.","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"2296_CR14","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","volume":"75","author":"P Osmancik","year":"2020","unstructured":"Osmancik P, Herman D, Neuzil P, et al. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2020;75(25):3122\u201335. https:\/\/doi.org\/10.1016\/j.jacc.2020.04.067.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2296_CR15","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jcin.2020.09.051","volume":"14","author":"JE Nielsen-Kudsk","year":"2021","unstructured":"Nielsen-Kudsk JE, Korsholm K, Damgaard D, et al. Clinical outcomes associated with left\u00a0atrial appendage occlusion versus\u00a0direct oral anticoagulation in atrial fibrillation. JACC Cardiovasc Interv. 2021;14(1):69\u201378. https:\/\/doi.org\/10.1016\/j.jcin.2020.09.051.","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"2296_CR16","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1161\/CIRCULATIONAHA.122.062765","volume":"147","author":"EP Zeitler","year":"2023","unstructured":"Zeitler EP, Kearing S, Coylewright M, et al. Comparative effectiveness of left atrial appendage occlusion versus oral anticoagulation by sex. Circulation. 2023;147(7):586\u201396. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.122.062765.","journal-title":"Circulation"},{"issue":"6","key":"2296_CR17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1161\/CIRCULATIONAHA.123.064702","volume":"148","author":"T Jiao","year":"2023","unstructured":"Jiao T, Ruzieh M. Letter by Jiao and Ruzieh regarding article, \u201cComparative effectiveness of left atrial appendage occlusion versus oral anticoagulation by sex.\u201d Circulation. 2023;148(6):508\u20139. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.064702.","journal-title":"Circulation"},{"issue":"8","key":"2296_CR18","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n MA, Robins JM. Using big data to emulate a target trial when a randomized trial is not available. Am J Epidemiol. 2016;183(8):758\u201364. https:\/\/doi.org\/10.1093\/aje\/kwv254.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"2296_CR19","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1097\/EDE.0b013e3181875e61","volume":"19","author":"MA Hern\u00e1n","year":"2008","unstructured":"Hern\u00e1n MA, Alonso A, Logan R, et al. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology. 2008;19(6):766\u201379. https:\/\/doi.org\/10.1097\/EDE.0b013e3181875e61.","journal-title":"Epidemiology"},{"issue":"24","key":"2296_CR20","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1001\/jama.2022.21383","volume":"328","author":"MA Hern\u00e1n","year":"2022","unstructured":"Hern\u00e1n MA, Wang W, Leaf DE. Target trial emulation: a framework for causal inference from observational data. JAMA. 2022;328(24):2446\u20137. https:\/\/doi.org\/10.1001\/jama.2022.21383.","journal-title":"JAMA"},{"issue":"4","key":"2296_CR21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.124.011188","volume":"18","author":"JZ Zhao","year":"2025","unstructured":"Zhao JZ, Ruzieh M, Du F, et al. Association between use of WATCHMAN device and 1-year mortality using high-dimensional propensity scores to reduce confounding. Circ Cardiovasc Qual Outcomes. 2025;18(4):e011188. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.124.011188.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"8","key":"2296_CR22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/pds.1230","volume":"15","author":"SE Andrade","year":"2006","unstructured":"Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiology and Drug. 2006;15(8):565\u201374. https:\/\/doi.org\/10.1002\/pds.1230.","journal-title":"Pharmacoepidemiology and Drug"},{"issue":"10","key":"2296_CR23","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.18553\/jmcp.2019.25.10.1073","volume":"25","author":"SL Canfield","year":"2019","unstructured":"Canfield SL, Zuckerman A, Anguiano RH, et al. Navigating the wild west of medication adherence reporting in specialty pharmacy. JMCP. 2019;25(10):1073\u20137. https:\/\/doi.org\/10.18553\/jmcp.2019.25.10.1073.","journal-title":"JMCP"},{"issue":"24","key":"2296_CR24","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","volume":"70","author":"VY Reddy","year":"2017","unstructured":"Reddy VY, Doshi SK, Kar S, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017;70(24):2964\u201375. https:\/\/doi.org\/10.1016\/j.jacc.2017.10.021.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2296_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","volume":"79","author":"P Osmancik","year":"2022","unstructured":"Osmancik P, Herman D, Neuzil P, et al. 4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation. J Am Coll Cardiol. 2022;79(1):1\u201314. https:\/\/doi.org\/10.1016\/j.jacc.2021.10.023.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2296_CR26","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1056\/NEJMoa1007432","volume":"364","author":"SJ Connolly","year":"2011","unstructured":"Connolly SJ, Eikelboom J, Joyner C, et al. Apixaban in patients with atrial fibrillation. N Engl J Med. 2011;364(9):806\u201317. https:\/\/doi.org\/10.1056\/NEJMoa1007432.","journal-title":"N Engl J Med"},{"issue":"22","key":"2296_CR27","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","volume":"384","author":"RP Whitlock","year":"2021","unstructured":"Whitlock RP, Belley-Cote EP, Paparella D, et al. Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med. 2021;384(22):2081\u201391. https:\/\/doi.org\/10.1056\/NEJMoa2101897.","journal-title":"N Engl J Med"},{"issue":"0 1","key":"2296_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/pds.2317","volume":"21","author":"PN Jensen","year":"2012","unstructured":"Jensen PN, Johnson K, Floyd J, Heckbert SR, Carnahan R, Dublin S. Identifying atrial fibrillation from electronic medical data: a systematic review. Pharmacoepidemiol Drug Saf. 2012;21(0 1):141\u20137. https:\/\/doi.org\/10.1002\/pds.2317.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"2296_CR29","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/pds.1869","volume":"19","author":"S Hennessy","year":"2010","unstructured":"Hennessy S, Leonard CE, Freeman CP, et al. Validation of diagnostic codes for outpatient-originating sudden cardiac death and ventricular arrhythmia in Medicaid and Medicare claims data. Pharmacoepidemiol Drug Saf. 2010;19(6):555\u201362. https:\/\/doi.org\/10.1002\/pds.1869.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02296-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02296-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-026-02296-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:54:41Z","timestamp":1792572881000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10840-026-02296-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,26]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["2296"],"URL":"https:\/\/doi.org\/10.1007\/s10840-026-02296-9","relation":{},"ISSN":["1572-8595"],"issn-type":[{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,26]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Conflicts of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}